Literature DB >> 7033479

Dopamine and [D-ALA2, D-Leu5]enkephalin inhibit the electrically stimulated neurohypophyseal release of vasopressin in vitro: evidence for calcium-dependent opiate action.

S L Lightman, L L Iversen, M L Forsling.   

Abstract

The effects of both dopamine and enkephalin agonists were assessed on electrically stimulated vasopressin secretion from the isolated neural lobe. Both dopamine (10(-6) M) and the dopamine agonist ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene; 10(-6) M) significantly reduced the stimulated release of vasopressin. This reduction in vasopressin secretion was prevented by the dopamine antagonist sulpiride (10(-6) M). [D-Ala2, D-Leu5]Enkephalin (DADLE) also inhibited vasopressin release and its effect was additive to that of ADTN. The effect of DADLE was prevented by the opiate antagonist naloxone and was also sensitive to the calcium content of the medium. Low calcium concentrations markedly increased the inhibitory effect of DADLE, while high concentrations abolished its effect. These findings provide evidence of a direct inhibitory action of both dopamine and enkephalins at the level of the neural lobe and suggest that the effect of enkephalins may be intimately related to calcium-sensitive neurosecretory events.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7033479      PMCID: PMC6564287     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  17 in total

1.  delta opioid receptor modulation of several voltage-dependent Ca(2+) currents in rat sensory neurons.

Authors:  C G Acosta; H S López
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Regulation of phosphorylation of proteins I, IIIa, and IIIb in rat neurohypophysis in vitro by electrical stimulation and by neuroactive agents.

Authors:  K Tsou; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

3.  An immunoelectron microscopic study of peptide substances in the rat neurohypophysis.

Authors:  C G Zhu; A Q Chen; Q Y Liu; Y Wei; X L Peng
Journal:  J Tongji Med Univ       Date:  1989

Review 4.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

5.  Immunocytochemical localization of LHRH in the median eminence, infundibular stalk, and neurohypophysis. Evidence for multiple sites of releasing hormone secretion in humans and other mammals.

Authors:  E L Anthony; J C King; E G Stopa
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

6.  Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists.

Authors:  G Dayanithi; E L Stuenkel; J J Nordmann
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

7.  Central effects of dopamine on vasopressin release in the normally hydrated and water-loaded rat.

Authors:  M L Forsling; H Williams
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

8.  Do opioid peptides modulate, at the level of the nerve endings, the release of neurohypophysial hormones?

Authors:  J J Nordmann; G Dayanithi; M Cazalis
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

9.  The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.

Authors:  W Knepel; D K Meyer
Journal:  J Physiol       Date:  1983-08       Impact factor: 5.182

10.  Differential effects of various opioid peptides on vasopressin and oxytocin release from the rat pituitary in vitro.

Authors:  D Maysinger; I Vermes; F Tilders; B R Seizinger; C Gramsch; V Höllt; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.